title: [Effect of veroshpiron on hormone level in patients with Parkinson's disease].
abstract: Blood hormones and urinary excretion of corticosteroids were measured in 39 parkinsonian patients receiving chemotherapy with adjuvant 3-week course of verospiron (50-100 mg/day). The latter promoted normalization of endocrine and clinical statuses in the majority of the patients. It is suggested that the response may be obtained via neuropeptide systems of the brain.
authors.forename: M Kh
authors.initials: MKh
authors.lastname: Karimova
authors.forename: K Z
authors.initials: KZ
authors.lastname: Vartanian
authors.forename: L S
authors.initials: LS
authors.lastname: Petelin
authors.forename: A A
authors.initials: AA
authors.lastname: Kubatiev
mesh_terms: D000305:Adrenal Cortex Hormones / Q000378:metabolism*; D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000378:metabolism*; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism*; D013148:Spironolactone / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D013148:Spironolactone; D000450:Aldosterone
vernacular_title: Vliianie veroshpirona na gormonalńyĭ profil u bolńykh Parkinsonizmom.